Prediction of absorbed dose by tumors and critical organs after Lu-177-DOTATATE therapy using pretherapeutic Ga-68-DOTATOC PET/CT

被引：0
|
作者：
Kim, Yong-il [1 ]
Oh, Jungsu [1 ]
Yoo, Changhoon [1 ]
Ryoo, Baek-Yeol [1 ]
Ryu, Jin-Sook [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
76
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
    Bessac, Darejan Mamulashvili
    Baltzinger, Philippe
    Poterszman, Nathan
    Van, Floriane Pham
    Collen, Cedric
    Malouf, Gabriel G.
    Ouvrard, Eric
    Kaseb, Ashjan
    Porot, Clemence
    Ben Abdelghani, Meher
    Addeo, Pietro
    Mertz, Luc
    Goichot, Bernard
    Imperiale, Alessio
    ENDOCRINE, 2025, 87 (03) : 1333 - 1341
  • [22] Visual and whole-body quantitative analyses of 68Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE
    Hotta, Masatoshi
    Sonni, Ida
    Thin, Pan
    Nguyen, Kathleen
    Gardner, Linda
    Ciuca, Liliana
    Hayrapetian, Artineh
    Lewis, Meredith
    Lubin, David
    Allen-Auerbach, Martin
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (04) : 296 - 304
  • [23] Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE
    Masatoshi Hotta
    Ida Sonni
    Pan Thin
    Kathleen Nguyen
    Linda Gardner
    Liliana Ciuca
    Artineh Hayrapetian
    Meredith Lewis
    David Lubin
    Martin Allen-Auerbach
    Annals of Nuclear Medicine, 2024, 38 : 296 - 304
  • [24] Inflammation based index and tumor heterogeneity on pretherapeutic 68Ga DOTATOC PET/CT predict outcome in midgut neuroendocrine tumor patients treated with 177Lu-oxodotreotide
    Vija, L.
    Dierickx, L.
    Kanoun, S.
    Texier, J. S.
    Terroir, M.
    Zerdoud, S.
    Brillouet, S.
    Vallot, D.
    Guimbaud, R.
    Savagner, F.
    Courbon, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 210 - 210
  • [25] Enhancing precision: A predictive model for 177 Lu- DOTATATE treatment response in neuroendocrine tumors using quantitative 68 Ga-DOTATATE PET and clinicopathological biomarkers
    Akhavanallaf, Azadeh
    Joshi, Sonal
    Mohan, Arathi
    Worden, Francis P.
    Krauss, John C.
    Zaidi, Habib
    Frey, Kirk
    Suresh, Krithika
    Dewaraja, Yuni K.
    Wong, Ka Kit
    THERANOSTICS, 2024, 14 (09): : 3708 - 3718
  • [26] The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors
    Metser, Ur
    Eshet, Yael
    Ortega, Claudia
    Veit-Haibach, Patrick
    Liu, Amy
    K. S. Wong, Rebecca
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (01) : 73 - 77
  • [27] Use of 68Ga-DOTA-TATE PET/CT for predicting the dose of 177Lu-DOTA-TATE therapy in patients with neuroendocrine tumors (NETs)
    Scheler, Simone
    Fischer, Richard
    Fani, Melpomeni
    Maecke, Helmut
    Weber, Wolfgang
    Wild, Damian
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [28] The effect of tumor burden in 68GA-PSMA-PET/CT on tracer uptake into kidneys in 68Ga-PSMA-PET/CT and the absorbed dose per administered GBq 177Lu-PSMA-617 during a following therapy
    Wichert, J.
    Happel, C.
    Kranert, W. T.
    Groener, D.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Mader, N.
    Banek, S.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S423 - S424
  • [29] PSMA Radioligand therapy: Does the pretherapeutic SUV in Ga-68 PSMA PET/CT predict the therapeutic tumor uptake and absorbed tumor dose?
    Schuchardt, C.
    Wiessalla, S.
    Singh, A.
    Zhang, J.
    Kulkarni, H. R.
    Mueller, D.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S170 - S171
  • [30] Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)
    Vega-Zolano, Elizabeth
    Ruiz, Erika
    Caderillo-Ruiz, German
    Diaz, Consuelo
    Herrera, Marytere
    Torres Agredo, Liliana Patricia
    Soldevilla-Gallardo, Irma
    Michel-Sanchez, Emiliano
    Garcia-Perez, Francisco Osvaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345